BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Acetaminophen, rs3825942, EGFR, G-protein-coupled receptor binding, Influenza, Lung)
Bookmark Forward

QuickView for REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN (biogroup)


Body Atlas

Most Correlated Tissues

  1. Pancreas
  2. Duodenum
  3. Pituitary gland
  4. Stomach pyloric
  5. Stomach
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Abnormal gravitational state
  2. Hemorrhagic shock
  3. Bacterial septicemia
  4. Chronic interstitial cystitis
  5. Intestinal infection due to Pseudomonas
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  2. 4-hydroxyestradiol-17 beta
  3. CGP 60474
  4. WHI P97
  5. 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. CrebA
  2. PCDH11X
  3. ANKRD2
  4. RPN1
  5. PCDH11X
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Gastric enterochromaffin-like (ECL) and parietal (PCL) cells from rats after 24hr fasting
  2. Pancreatic mRNA expression profiles throughout differentiation
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
  4. Drosophila larvae tissue-specific gene expression 18hr before puparium formation
  5. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.